Long-term response to zonisamide in patients with West syndrome
- PMID: 12034801
- DOI: 10.1212/wnl.58.10.1556
Long-term response to zonisamide in patients with West syndrome
Abstract
The long-term effectiveness of zonisamide (ZNS) was evaluated in 11 patients with West syndrome (7 symptomatic) who had cessation of spasms with ZNS monotherapy. During the follow-up period (24 to 79 months, mean = 53 months), this response was maintained in 7 patients (3 symptomatic, relapse rate = 36%), including 2 children in whom ZNS was successfully discontinued. No serious adverse reactions were noted. ZNS may be both effective and well tolerated for the treatment of West syndrome.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources